Canada warns about drug mix-up caused by similar names

11/9/2011 | CBC.ca (Canada)

Health Canada said five cases have been reported this year involving a drug mix-up of Pradax, by Boehringer Ingelheim, and Plavix, by Sanofi and Bristol-Myers Squibb, because of their similar trade names. One case resulted in nonserious bleeding after a medical procedure. Taking one drug when the other is prescribed could increase the risk of bleeding, heart attack or blood clots, the health agency said.

View Full Article in:

CBC.ca (Canada)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC